Apimeds Pharmaceuticals US Insider Trades
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Apimeds Pharmaceuticals US insider activity
No Apimeds Pharmaceuticals US insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Kim Christopher (Chairman and CMO) reporting a transaction in 250,000 shares on May 16, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put APUS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
APUS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 16, 2025 | Emerson Erik C.Chief Executive Officer | Award | 750,000 | — | Form 4 |
| May 16, 2025 | Kim ChristopherChairman and CMO | Award | 250,000 | — | Form 4 |
| May 14, 2025 | Kim ChristopherChairman and CMO | Buy | 7,730 | $14.38K | Form 4 |
| May 13, 2025 | Kim ChristopherChairman and CMO | Buy | 19,770 | $35.98K | Form 4 |
| May 12, 2025 | Koo JakapDirector | Buy | 28,500 | $56.72K | Form 4 |
| May 12, 2025 | Inscobee Inc.10% Owner | Conversion | 44,041 | $114.51K | Form 4 |
| May 12, 2025 | Inscobee Inc.10% Owner | Conversion | 71,090 | $184.83K | Form 4 |
| May 12, 2025 | Inscobee Inc.10% Owner | Conversion | 182,002 | $473.21K | Form 4 |
| May 12, 2025 | Inscobee Inc.10% Owner | Buy | 500,000 | $2.00M | Form 4 |
| May 12, 2025 | Inscobee Inc.10% Owner | Conversion | 44,041 | $114.51K | Form 4 |
| May 12, 2025 | Inscobee Inc.10% Owner | Conversion | 71,090 | $184.83K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4